检索结果 - Attard, G

Prostate epithelial stem cells 由 Rizzo, S., Attard, G., Hudson, D. L.

获取全文 获取全文 获取全文

Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects 由 Ferraldeschi, R, Welti, J, Luo, J, Attard, G, de Bono, JS

获取全文 获取全文 获取全文

Improving the outcome of patients with castration-resistant prostate cancer through rational drug development 由 Attard, G, Sarker, D, Reid, A, Molife, R, Parker, C, de Bono, J S

获取全文 获取全文 获取全文

Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail 由 Ong, M, Carreira, S, Goodall, J, Mateo, J, Figueiredo, I, Rodrigues, D N, Perkins, G, Seed, G, Yap, T A, Attard, G, de Bono, J S

获取全文 获取全文 获取全文

A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours 由 Attard, G, Kitzen, J, Blagden, S P, Fong, P C, Pronk, L C, Zhi, J, Zugmaier, G, Verweij, J, de Bono, J S, de Jonge, M

获取全文 获取全文 获取全文

Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer 由 Pezaro, C, Mukherji, D, Tunariu, N, Cassidy, A M, Omlin, A, Bianchini, D, Seed, G, Reid, A H M, Olmos, D, de Bono, J S, Attard, G

获取全文 获取全文 获取全文

Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer 由 Omlin, A, J Pezaro, C, Zaidi, S, Lorente, D, Mukherji, D, Bianchini, D, Ferraldeschi, R, Sandhu, S, Dearnaley, D, Parker, C, Van As, N, de Bono, J S, Attard, G

获取全文 获取全文 获取全文

Reply: ‘Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' 由 Omlin, A, Pezaro, C J, Zaidi, S, Lorente, D, Mukherji, D, Bianchini, D, Ferraldeschi, R, Sandhu, S, Dearnaley, D, Parker, C, Van As, N, de Bono, J S, Attard, G

获取全文 获取全文 获取全文

Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone 由 Salvi, S, Casadio, V, Conteduca, V, Burgio, S L, Menna, C, Bianchi, E, Rossi, L, Carretta, E, Masini, C, Amadori, D, Calistri, D, Attard, G, De Giorgi, U

获取全文 获取全文 获取全文

The STAMPEDE2 Trial: a Site Survey of Current Patterns of Care, Access to Imaging and Treatment of Metastatic Prostate Cancer 由 Abdel-Aty, H., O’Shea, L., Amos, C., Brown, L.C., Grist, E., Attard, G., Clarke, N., Cross, W., Parker, C., Parmar, M., Vas As, N., James, N.

获取全文 获取全文 获取全文

Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone 由 Lorente, D, Omlin, A, Ferraldeschi, R, Pezaro, C, Perez, R, Mateo, J, Altavilla, A, Zafeirou, Z, Tunariu, N, Parker, C, Dearnaley, D, Gillessen, S, de Bono, J, Attard, G

获取全文 获取全文 获取全文

Visceral disease in castration-resistant prostate cancer 由 Pezaro, C., Omlin, A., Lorente, D., Rodrigues, D. Nava, Ferraldeschi, R., Bianchini, D., Mukherji, D., Riisnaes, R., Altavilla, A., Crespo, M., Tunariu, N., de Bono, J., Attard, G.

获取全文 获取全文 获取全文

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement 由 Foster, C S, Dodson, A R, Ambroisine, L, Fisher, G, Møller, H, Clark, J, Attard, G, De-Bono, J, Scardino, P, Reuter, V E, Cooper, C S, Berney, D M, Cuzick, J

获取全文 获取全文 获取全文

Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone 由 Massard, C., Mateo, J., Loriot, Y., Pezaro, C., Albiges, L., Mehra, N., Varga, A., Bianchini, D., Ryan, C. J., Petrylak, D. P., Attard, G., Shen, L., Fizazi, K., de Bono, J.

获取全文 获取全文 获取全文

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer 由 Attard, G, Clark, J, Ambroisine, L, Fisher, G, Kovacs, G, Flohr, P, Berney, D, Foster, CS, Fletcher, A, Gerald, WL, Moller, H, Reuter, V, De Bono, JS, Scardino, P, Cuzick, J, Cooper, CS

获取全文 获取全文 获取全文

Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer 由 Attard, G, Clark, J, Ambroisine, L, Mills, I G, Fisher, G, Flohr, P, Reid, A, Edwards, S, Kovacs, G, Berney, D, Foster, C, Massie, C E, Fletcher, A, De Bono, J S, Scardino, P, Cuzick, J, Cooper, C S

获取全文 获取全文 获取全文

Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents 由 Crespo, M, van Dalum, G, Ferraldeschi, R, Zafeiriou, Z, Sideris, S, Lorente, D, Bianchini, D, Rodrigues, D N, Riisnaes, R, Miranda, S, Figueiredo, I, Flohr, P, Nowakowska, K, de Bono, J S, Terstappen, L W M M, Attard, G

获取全文 获取全文 获取全文

Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer 由 Leibowitz-Amit, R., Templeton, A. J., Omlin, A., Pezaro, C., Atenafu, E. G., Keizman, D., Vera-Badillo, F., Seah, J.-A., Attard, G., Knox, J. J., Sridhar, S. S., Tannock, I. F., de Bono, J. S., Joshua, A. M.

获取全文 获取全文 获取全文

First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate can... 由 Bianchini, D, Omlin, A, Pezaro, C, Lorente, D, Ferraldeschi, R, Mukherji, D, Crespo, M, Figueiredo, I, Miranda, S, Riisnaes, R, Zivi, A, Buchbinder, A, Rathkopf, D E, Attard, G, Scher, H I, de Bono, J, Danila, D C

获取全文 获取全文 获取全文

Transcriptional profiling of primary prostate tumor in metastatic hormone sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAART... 由 Hamid, A. A., Huang, H-C., Wang, V., Chen, Y-H., Feng, F., Den, R., Attard, G., Van Allen, E. M., Tran, P. T., Spratt, D. E., Dittamore, R., Davicioni, E., Liu, G., DiPaola, R., Carducci, M. A., Sweeney, C. J.

获取全文 获取全文 获取全文